Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03358810 · ClinicalTrials.gov registry record · NA
Pharyngeal Electrical Stimulation Evaluation for Dysphagia After Stroke
A NA study, sponsored by Phagenesis.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT03358810 is a NA study that has completed, run by Phagenesis. The registered enrollment target is 50 participants.
The verdict
NCT03358810, a NA study, has completed, sponsored by Phagenesis.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This is a randomized, sham-controlled, patient masked, outcome assessor-blinded study to assess a Pharyngeal Electrical Stimulation (PES) Catheter for treatment of oropharyngeal dysphagia following a stroke.
Interventions
- DEVICE PES
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2018-03-31 |
| Est. Completion | 2020-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03358810
The ClinicalTrials.gov registry entry for NCT03358810 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Phagenesis, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PES is the first listed.
NCT03358810 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03358810 about?
NCT03358810 is a clinical study titled "Pharyngeal Electrical Stimulation Evaluation for Dysphagia After Stroke". This is a randomized, sham-controlled, patient masked, outcome assessor-blinded study to assess a Pharyngeal Electrical Stimulation (PES) Catheter for treatment of oropharyngeal dysphagia following a stroke.
What is the current status of trial NCT03358810?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2018-03-31. Estimated completion is 2020-05-01.
What interventions are being tested in trial NCT03358810?
The interventions under investigation include: PES (DEVICE).
Who is sponsoring clinical trial NCT03358810?
This trial is sponsored by Phagenesis, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.